Delivery Order SPE2DB22D1200-SPE2DB25FN2VS
Award Date
6/30/25
Potential Completion Date
7/1/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 5-320 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $2,013.65 and is a firm fixed price contract. The period of performance runs through May 12, 2025. This award is not associated with a set-aside and appears to be open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 10-320 MG TABLET 30S, a type of medication, with a ceiling value of $3,989.54 and a performance period ending on July 2, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $5,432.81 and a performance period ending on May 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $14,436.25 and a period of performance ending on July 3, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is also the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a total ceiling value of $2,465.80. The contract is a firm fixed-price, non-set-aside award with a completion date of June 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $3,446.96 and a period of performance through June 30, 2025. The contract is not set-aside and was awarded on June 27, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EXFORGE 5-160 MG TABLET 30S. The firm-fixed-price contract has a ceiling value of $3,103.17 and a period of performance through August 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award is a firm fixed price delivery order worth $3,255.22 granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a for-profit subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of February 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,071.78 firm fixed price contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA to supply...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of EXFORGE 5-320 MG TABLET 30S. The order, valued at $2,368.71, is a firm fixed-price contract with a completion date of September 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...